<DOC>
	<DOC>NCT01043185</DOC>
	<brief_summary>The purpose of the study is to estimate what effect 4 different doses of AZD3355 will have on the number of reflux episodes, in patients who have GERD and still experience symptoms despite proton pump inhibitor (PPI) treatment.</brief_summary>
	<brief_title>A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lesogaberan</mesh_term>
	<criteria>Provide informed consent History of GERD with persistent symptoms despite treatment with PPI Otherwise normal physical health History of GERD with symptoms that has not improved at all during treatment with PPI Prior surgery of the upper gastrointestinal tract History of significant heart disease, cardiovascular, respiratory, hepatic, renal, metabolic, psychiatric or gastrointestinal disorders besides GERD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>GERD</keyword>
	<keyword>lesogaberan</keyword>
	<keyword>impedance</keyword>
	<keyword>pH</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
</DOC>